Cresco Labs Inc. (CRLBF)

Market Cap	538.88M
Revenue (ttm)	765.36M
Net Income (ttm)	-152.51M
Shares Out	328.59M
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	113.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,295
Open	1.720
Previous Close	1.740
Day's Range	1.630 - 1.720
52-Week Range	1.000 - 2.770
Beta	1.98
Analysts	Buy
Price Target	2.50 (+52.44%)
Earnings Date	n/a

About CRLBF

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2013
• Employees: 2,760
• Stock Exchange: OTCMKTS
• Ticker Symbol: CRLBF

Financial Performance

In 2023, Cresco Labs's revenue was $785.02 million, a decrease of -6.84% compared to the previous year's $842.68 million. Losses were -$178.74 million, -17.19% less than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for CRLBF stock is "Buy." The 12-month stock price forecast is $2.5, which is an increase of 52.44% from the latest price.

Price Target

$2.5

(52.44% upside)

Analyst Consensus: Buy